摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-Dihydro-5-methyl-2H-1,2,6-thiadiazin-3(4H)-one 1,1-dioxide | 36935-58-7

中文名称
——
中文别名
——
英文名称
5,6-Dihydro-5-methyl-2H-1,2,6-thiadiazin-3(4H)-one 1,1-dioxide
英文别名
5-methyl-1,1-dioxo-1λ6-[1,2,6]thiadiazinan-3-one;5-Methyl-1,1-dioxo-1,2,6-thiadiazinan-3-one
5,6-Dihydro-5-methyl-2H-1,2,6-thiadiazin-3(4H)-one 1,1-dioxide化学式
CAS
36935-58-7
化学式
C4H8N2O3S
mdl
——
分子量
164.185
InChiKey
NSTKOPDXHKHGBN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    83.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents
    作者:Magid Abou-Gharbia、John A. Moyer、Usha Patel、Michael Webb、Guy Schiehser、Terrance Andree、J. Thomas Haskins
    DOI:10.1021/jm00125a016
    日期:1989.5
    Several novel substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones were prepared and examined in a series of in vitro and in vivo tests to determine their pharmacological profile. Most compounds were orally active in blocking the conditioned avoidance response (CAR) but did not antagonize apomorphine-induced stereotyped behavior. Several compounds demonstrated
    制备了几种新颖的取代的四氢-和六氢-1,2-苯并噻唑-3-一和1,1-二氧化物和噻二嗪酮,并在一系列体外和体内试验中进行了研究,以确定它们的药理作用。大多数化合物在阻止条件性回避反应(CAR)方面具有口服活性,但不能拮抗阿扑吗啡引起的刻板印象。几种化合物对5-HT1A受体的结合位点表现出中等至高的亲和力,其中含有2-嘧啶基哌嗪基和[3-(三氟甲基)苯基]哌嗪基部分的化合物37和38和含有2-吡嗪基哌嗪基部分的化合物47表现出最高的亲和力( Ki值分别为10、4和9 nM。化合物37,3- [4- [4-(2-嘧啶基)-1-哌嗪基]丁基]六氢-4,7-乙炔基-1H-环丁[[f] -1,2-苯并噻唑-3(2H)- 1,1-二氧化物 丁螺环酮和ipsapirone的神经化学和行为特征相似。它们在阻断CAR方面的功效相似,AB50分别为39、32和42 mg / kg。他们还显示了对5-HT1A受体位点的高亲和力和选择性(Ki
  • Bicyclic spirosulfonimides with psychotropic activity
    申请人:American Home Products Corporation
    公开号:US04709027A1
    公开(公告)日:1987-11-24
    There are disclosed compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each, independently, hydrogen or lower alkyl, or R.sup.1 and R.sup.2 taken together represent ##STR2## A is O or NR.sup.3 ; B is --(CH.sub.2).sub.n --, ##STR3## R.sup.3 is hydrogen or lower alkyl; R.sup.4 is hydrogen, lower alkyl, aryl of 6-12 carbon atoms or halo; R.sup.5 is unsubstituted or substituted phenyl, 2-pyridinyl, 2-pyrimidinyl, 2-pyrazinyl or 3-pyridazinyl, where the substituents are selected from the group lower alkyl, lower alkoxy, halo, cyano, nitro and trifluoromethyl; Z is --(CH.sub.2).sub.n -- or vinylene; X is lower alkylene, vinylene or O; m is 2-5; n is 1-3; o is 1-5; and the pharmaceutically acceptable salts thereof and their use as antipsychotic/anxiolytic agents having a low liability for extrapyramidal side effects.
    公开了式子为##STR1##的化合物,其中R.sup.1和R.sup.2各自独立地为氢或低碳基,或R.sup.1和R.sup.2结合在一起代表##STR2##A为O或NR.sup.3; B为--(CH.sub.2).sub.n --,##STR3##R.sup.3为氢或低碳基;R.sup.4为氢,低碳基,6-12个碳原子的芳基或卤素;R.sup.5为未取代或取代的苯基,2-吡啶基,2-嘧啶基,2-吡嗪基或3-吡啉嗪基,其中取代基选自群体低碳基,低氧基,卤素,氰基,硝基和三氟甲基;Z为--(CH.sub.2).sub.n --或乙烯基;X为低碳基,乙烯基或O;m为2-5;n为1-3;o为1-5;以及其药学上可接受的盐和作为抗精神病/抗焦虑剂使用,具有低额外锥体副作用的作用。
  • ABOU-GHARBIA, MAGID A.;SCHIEHSER, GUY A.
    作者:ABOU-GHARBIA, MAGID A.、SCHIEHSER, GUY A.
    DOI:——
    日期:——
  • Die,R. et al., Journal of Heterocyclic Chemistry, 1972, vol. 9, p. 973
    作者:Die,R. et al.
    DOI:——
    日期:——
查看更多

同类化合物

牛磺胺 滔罗林 棉隆 四氢-5-(2-羟基乙基)-3-甲基-2H-1,3,5-噻二嗪-2-硫酮 四氢-3,5-二甲基-4,6-二苯基-2H-1,3,5-噻二嗪-2-硫酮 噻嗪酮 7-氧杂-2-硫杂-1,5-二氮杂双环[3.3.1]壬烷 4,6-二甲基-四氢-[1,3,5]噻二嗪-2-硫酮 3-异丙基-5-苯基-1,3,5-噻二嗪-2,4-二酮 3,5-二己基-1,3,5-噻二嗪烷-2-硫酮 3,4,5,6-四氢-4,6-二甲基-2-(3-吡啶基)-2H-1,3,4-噻二嗪 2-苯甲基-1,2,6-噻重氮基己环1,1-二氧化 2-甲基-[1,2,6]噻二烷 1,1-二氧化物 2,6-二甲基-4-(2-甲基丙基)-2H-1,2,6-噻二嗪-3,5(4H,6H)-二酮1,1-二氧化物 2,6-二丁基-4-(2-甲基丙基)-2H-1,2,6-噻二嗪-3,5(4H,6H)-二酮1,1-二氧化 1Λ6,2,6-噻二嗪烷-1,1-二酮 3-benzyl-5-(3-carboxypropyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione 7-oxa-2<λ>6-thia-1,5-diazabicyclo<3.3.1>nonane-2,2-dione 5-carboxyethyl-3-(2´-furfurylmethyl)-1,3,5-thiadiazinane-2-thione 5-carboxyethyl-3-cyclohexyl-1,3,5-thiadiazinane-2-thione tert-butyl 1,2,6-thiadiazinan-2-carboxylate 1,1-dioxide 3-Phenyl-3,4,5,6-tetrahydro-2H-<1,2,3>thiadiazin-1,1-dioxid 5-(2-hydroxyethyl)-3-n-propyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-i-butyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 2-[1-(4-pyridyl)ethyl]tetrahydro-1,2,6-thiadiazine-1,1-dioxide 2-Thio-3-phenaethyl-5-(2-hydroxy-aethyl)-tetrahydro-1,3,5-thiadiazin 3-cyclohexyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 5-(2-hydroxyethyl)-3-(1-phenylethyl)-1,3,5-thiadiazinane-2-thione 5-(2-hydroxyethyl)-3-n-pentyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 5-(2-hydroxyethyl)-3-i-propyl-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-ethyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-n-hexyl-5-(2-hydroxyethyl)-3,4,5,6-tetrahydro-2H-1,3,5-thiadiazine-2-thione 3-Benzyl-5-[2-(diethylamino)ethyl]-1,3,5-thiadiazinane-2-thione;hydrochloride 4-[(5-Cyclohexyl-6-sulfanylidene-1,3,5-thiadiazinan-3-yl)methyl]cyclohexane-1-carboxylic acid 6-butyl-5-methyl-1,1-dioxo-1λ6-[1,2,6]thiadiazinan-3-one 2,4-dibutyl-[1,2,4]thiadiazinane 1,1-dioxide 2-[4-pyridylmethyl]tetrahydro-1,2,6-thiadiazine-1,1-dioxide 2-[2-(4-pyridyl)ethyl] tetrahydro-1,2,6-thiadiazine-1,1-dioxide 2-[2-(Pyridin-4-yl)propyl]-1lambda~6~,2,6-thiadiazinane-1,1-dione 3-Benzyl-5-methyl-1,3,5-thiadiazinane-2-thione 2,6-Dithia-1,3,7-triazaadamantane, 2,2,6,6-tetraoxide 3,5-Bis-<2-hydroxy-aethyl>-2-thioxo-tetrahydro-1,3,5-thiadiazin 5,6-Dihydro-5-methyl-2H-1,2,6-thiadiazin-3(4H)-one 1,1-dioxide 3-butyl-5-(2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione 3-benzyl-5-(2-hydroxyethyl)-1,3,5-thiadiazinane-2-thione 3-Benzyl-5-cyclohexyl-[1,3,5]thiadiazinane-2-thione 2-tert-butyl-2,4,6-trimethylperhydro-1,3,4-thiadiazine Homopentamethylenetetramine 3,5-Diisopropyl-1,3,5-thiadiazinane-2-thione 2,2,4,6-Tetramethyl-[1,3,4]thiadiazinane